SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-16-001064
Filing Date
2016-05-24
Accepted
2016-05-24 16:15:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 MAY 23, 2016 vistagen13ga-052316.htm SC 13G/A 88017
  Complete submission text file 0001013594-16-001064.txt   89614
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-86249 | Film No.: 161672045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022
Business Address 900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022 (212) 213-7033
NEXTHERA CAPITAL LP (Filed by) CIK: 0001646343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A